| Literature DB >> 30233523 |
Irene K Meki1,2, İkbal A İnce3,4, Henry M Kariithi1,5, Drion G Boucias6, Orhan Ozcan4, Andrew G Parker1, Just M Vlak2, Monique M van Oers2, Adly M M Abd-Alla1.
Abstract
The Glossina pallidipes salivary gland hypertrophy virus (GpSGHV) infects tsetse flies predominantly asymptomatically and occasionally symptomatically. Symptomatic infections are characterized by overt salivary gland hypertrophy (SGH) in mass reared tsetse flies, which causes reproductive dysfunctions and colony collapse, thus hindering tsetse control via sterile insect technique (SIT). Asymptomatic infections have no apparent cost to the fly's fitness. Here, small RNAs were sequenced and profiles in asymptomatically and symptomatically infected G. pallidipes flies determined. Thirty-eight host-encoded microRNAs (miRNAs) were present in both the asymptomatic and symptomatic fly profiles, while nine host miRNAs were expressed specifically in asymptomatic flies versus 10 in symptomatic flies. Of the shared 38 miRNAs, 15 were differentially expressed when comparing asymptomatic with symptomatic flies. The most up-regulated host miRNAs in symptomatic flies was predicted to target immune-related mRNAs of the host. Six GpSGHV-encoded miRNAs were identified, of which five of them were only in symptomatic flies. These virus-encoded miRNAs may not only target host immune genes but may also participate in viral immune evasion. This evidence of differential host miRNA profile in Glossina in symptomatic flies advances our understanding of the GpSGHV-Glossina interactions and provides potential new avenues, for instance by utilization of particular miRNA inhibitors or mimics to better manage GpSGHV infections in tsetse mass-rearing facilities, a prerequisite for successful SIT implementation.Entities:
Keywords: Glossina; GpSGHV; Hytrosaviridae; asymptomatic infection; immune system; miRNA; sterile insect technique; symptomatic
Year: 2018 PMID: 30233523 PMCID: PMC6129597 DOI: 10.3389/fmicb.2018.02037
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
A summary of sRNA from GpSGHV asymptomatically and symptomatically infected flies.
| Class of RNA | Asymptomatic library R1 | Symptomatic library R1 | Asymptomatic library R2 | Symptomatic library R2 | Asymptomatic library (total) | Symptomatic library (total) |
|---|---|---|---|---|---|---|
| Raw reads | 1,735,077 | 1,167,975 | 4,610,021 | 3,699,655 | 6,345,098 | 4,867,630 |
| Reads after quality filtering | 4,567 | 4,456 | 15,599 | 11,853 | 20,166 | 16,309 |
| Reads mapped to | 3,624 | 3,521 | 12,798 | 9,556 | 16,422 | 13,077 |
| Reads mapped to SGHV genome | 0 | 13 | 3 | 40 | 3 | 53 |
| 290 | 271 | 1,385 | 936 | 1,675 | 1,207 | |
| GpSGHV miRNAs reads | 0 | 0 | 1 | 6 | 1 | 6 |
| Unmapped reads | 943 | 935 | 757 | 526 | 1,700 | 1,461 |
| rRNA | 555 | 518 | 390 | 302 | 945 | 820 |
VMir predicted and sequenced GpSGHV pre-miRNA and their characteristics.
| MiRNA name | Pre-miRNA length | Pre-miRNA mfe (kcal/mol) | Strand | Position in GpSGHV genome | VMir score | Mature miRNA length | Mature miRNA location | Mature miRNA sequence (5′-3′) |
|---|---|---|---|---|---|---|---|---|
| Mir-GpSGHV_170050R | 145 | −41.60 | Reverse | 170050–170194 | 254.9 | 22 | 3p | CTACTTGGAGATATAATAGAAG |
| Mir-GpSGHV_165479R | 87 | −22.70 | Reverse | 165479–165565 | 217.9 | 22 | 3p | AAATGGATCGCTGTAGTTTTAA |
| Mir-GpSGHV_165481F | 83 | −21.0 | Forward | 165481–165564 | 214.1 | 22 | 3p | TGGATTACTCTGGTTTTAACTT |
| Mir-GpSGHV_165975R | 87 | −23.60 | Reverse | 165975–166062 | 180.7 | 22 | 3p | ATGGTTGAGATTCTTCAGATCG |
| Mir-GpSGHV_164791F | 66 | −19.0 | Forward | 164791–164857 | 137.4 | 22 | 3p | TGGATCAATGTATTTCCATCTC |
| Mir-GpSGHV_151557R | 55 | −9.30 | Reverse | 151532–151583 | 130 | 22 | 3p | GGACGTGTCATTATATAATCGG |
The top 10 predicted targets of the differentially expressed host and GpSGHV-encoded miRNAs.
| Target gene (VectoBase ID) | Gene name | miRNA | Molecular function/biological process |
|---|---|---|---|
| GPAI025158 | Homeodomain interacting protein kinase (Hipk) | miR-184-3p | ATP binding, protein kinase activity. Plays a role in cell proliferation and development |
| Mir-GpSGHV_165479R | |||
| miR-6497 | |||
| GPAI030501 | Ras-related protein Rab-27 | miR-184-3p | GTPase activity Source, GTP binding. Involved in exocytosis and phagocytosis |
| GPAI014544 | Fibrillin-1 (FBN1) | miR-184-3p | Calcium ion binding. Involved in cell communication |
| miR-31-5p | |||
| GPAI038987 | Protein-serine/threonine kinase (STKP) | miR-6497 | ATP binding, G-protein coupled receptor kinase activity. Involved in regulation of innate immune response and oogenesis |
| miR-9-3p | |||
| miR-263-5p | |||
| miR-184-3p | |||
| miR-276-5p | |||
| GPAI034557 | Apolipoprotein lipid transfer particle (Apoltp) | miR-184-3p | Lipid transporter activity, lipoprotein particle receptor binding. Provides the major yolk proteins during vitellogenesis |
| miR-999-3p | |||
| miR-6497 | |||
| miR-276-5p | |||
| miR-263-5p | |||
| miR-9-3p | |||
| Mir-GpSGHV_165479R | |||
| Mir-GpSGHV_165975R | |||
| Mir-GpSGHV_164791F | |||
| GPAI025990 | Transcription factor collier (TFCOE) | miR-6497 | DNA binding, metal ion binding. Involved in development |
| miR-9-3p | |||
| miR-263-5p | |||
| Mir-GpSGHV_165975R | |||
| Mir-GpSGHV_165479R | |||
| GPAI001218 | Twitchin | miR-6497 | ATP binding, protein kinase activity. Mesoderm development |
| miR-276-5p | |||
| miR-263-5p | |||
| miR-184-3p | |||
| miR-9-3p | |||
| miR-31-5p | |||
| miR-279-3p | |||
| Mir-GpSGHV_165975R | |||
| Mir-GpSGHV_164791F | |||
| Mir-GpSGHV_165482F | |||
| Mir-GpSGHV_165479R | |||
| GPAI015640 | Ras-related protein Ral-a (Rala) | miR-184-3p | GTPase activity, GTP binding. Innate immune response and signal transduction |
| miR-277-3p | |||
| miR-999-3p | |||
| miR-6497 | |||
| miR-263-5p | |||
| miR-276-5p | |||
| miR-9-3p | |||
| Mir-GpSGHV_151557R | |||
| Mir-GpSGHV_165975R | |||
| Mir-GpSGHV_164791F | |||
| Mir-GpSGHV_165479R | |||
| GPAI042543 | Vitellogenin receptor (VtgR) | miR-6497 | Calcium ion binding. Involved in uptake of vitellogenin by endocytosis during oogenesis |
| miR-184-3p | |||
| miR-276-5p | |||
| miR-263-5p | |||
| GPAI007448 | Centrosomal protein (CEP) | miR-184-3p | Centriole-centriole cohesion Source, centriole replication. Involved in spermatogenesis |
| miR-263-5p |